Receptor- and ligand-based study of fullerene analogues: comprehensive computational approach including quantum-chemical, QSAR and molecular docking simulations.
暂无分享,去创建一个
Jerzy Leszczynski | Danuta Leszczynska | Bakhtiyor Rasulev | J. Leszczynski | D. Leszczyńska | B. Rasulev | Lucky Ahmed | Malakhat Turabekova | Lucky Ahmed | M. Turabekova
[1] Soumi Banerjee. Molecular dynamics study of self-agglomeration of charged fullerenes in solvents. , 2013, The Journal of chemical physics.
[2] A. Ferrarini,et al. Monomeric fullerenes in lipid membranes: effects of molecular shape and polarity. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[3] Chi‐Huey Wong,et al. HIV-1 protease: mechanism and drug discovery. , 2003, Organic & biomolecular chemistry.
[4] Sanjay Mathur,et al. Graphene oxide, but not fullerenes, targets immunoproteasomes and suppresses antigen presentation by dendritic cells. , 2013, Small.
[5] L. Echegoyen,et al. Electrochemistry of Fullerenes and Their Derivatives , 1998 .
[6] Jerzy Leszczynski,et al. Improved model for fullerene C60 solubility in organic solvents based on quantum-chemical and topological descriptors , 2011 .
[7] Yuan-yuan Li,et al. Protective effect of C60‐methionine derivate on lead‐exposed human SH‐SY5Y neuroblastoma cells , 2011, Journal of applied toxicology : JAT.
[8] Alexandra Shulman-Peleg,et al. Interaction of c(60)-fullerene and carboxyfullerene with proteins: docking and binding site alignment. , 2006, Bioconjugate chemistry.
[9] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[10] N. Higashi,et al. Immobilization and cleavage of DNA at cationic, self-assembledmonolayers containing C60 on gold , 1997 .
[11] H. Okayama,et al. Gene delivery by aminofullerenes: structural requirements for efficient transfection. , 2006, Chemistry, an Asian journal.
[12] Xue Xu,et al. Multidrug resistance protein P-glycoprotein does not recognize nanoparticle C60: experiment and modeling , 2012 .
[13] Schmid,et al. "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.
[14] Serdar Durdagi,et al. 3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors. , 2008, Bioorganic & medicinal chemistry letters.
[15] R. Zhou,et al. Amino acid analogues bind to carbon nanotube via π-π interactions: comparison of molecular mechanical and quantum mechanical calculations. , 2012, The Journal of chemical physics.
[16] Yong Pan,et al. Prediction of the net heat of combustion of organic compounds based on atom-type electrotopological state indices , 2009 .
[17] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[18] P. Labute. A widely applicable set of descriptors. , 2000, Journal of molecular graphics & modelling.
[19] T. Luh,et al. Carboxyfullerene Prevents Iron‐Induced Oxidative Stress in Rat Brain , 1999, Journal of neurochemistry.
[20] D. Truhlar,et al. The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals , 2008 .
[21] K. Roy,et al. Exploring quantitative structure–activity relationship studies of antioxidant phenolic compounds obtained from traditional Chinese medicinal plants , 2010 .
[22] Ruhong Zhou,et al. Binding preference of carbon nanotube over proline-rich motif ligand on SH3-domain: a comparison with different force fields. , 2013, The journal of physical chemistry. B.
[23] Ya-Wen Chen,et al. Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.
[24] Zafar Iqbal,et al. Single-walled Carbon Nanotubes Are a New Class of Ion Channel Blockers* , 2003, Journal of Biological Chemistry.
[25] Johann Gasteiger,et al. Deriving the 3D structure of organic molecules from their infrared spectra , 1999 .
[26] Davide Giust,et al. [60]Fullerene-based monolayers as neuroprotective biocompatible hybrid materials. , 2011, Chemical Communications.
[27] Andrew G Mercader,et al. QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors. , 2010, European journal of medicinal chemistry.
[28] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[29] C. Wilkins,et al. Synthesis of a fullerene derivative for the inhibition of HIV enzymes , 1993 .
[30] Mark A. Ratner,et al. 6‐31G* basis set for third‐row atoms , 2001, J. Comput. Chem..
[31] Anderson Coser Gaudio,et al. BuildQSAR: A New Computer Program for QSAR Analysis , 2000 .
[32] Maykel Pérez González,et al. 2D-autocorrelation descriptors for predicting cytotoxicity of naphthoquinone ester derivatives against oral human epidermoid carcinoma. , 2007, Bioorganic & medicinal chemistry.
[33] Jarmo Huuskonen,et al. Estimation of Aqueous Solubility for a Diverse Set of Organic Compounds Based on Molecular Topology , 2000, J. Chem. Inf. Comput. Sci..
[34] Carsten Bingel,et al. Cyclopropanierung von Fullerenen , 1993 .
[35] T. Puzyn,et al. Toward the development of "nano-QSARs": advances and challenges. , 2009, Small.
[36] Stephen R. Wilson,et al. [60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. , 2005, Nano letters.
[37] Paola Gramatica,et al. Structure/Response Correlations and Similarity/Diversity Analysis by GETAWAY Descriptors, 2. Application of the Novel 3D Molecular Descriptors to QSAR/QSPR Studies , 2002, J. Chem. Inf. Comput. Sci..
[38] Eiichi Nakamura,et al. Photoinduced biochemical activity of fullerene carboxylic acid , 1993 .
[39] Zhen Cao,et al. Molecular Dynamics Simulation of Fullerene C60 in Ethanol Solution , 2009 .
[40] Igor V. Tetko,et al. Neural Network Modeling for Estimation of Partition Coefficient Based on Atom-Type Electrotopological State Indices , 2000, J. Chem. Inf. Comput. Sci..
[41] Magdalena Bacilieri,et al. Prediction of the aqueous solvation free energy of organic compounds by using autocorrelation of molecular electrostatic potential surface properties combined with response surface analysis. , 2008, Bioorganic & medicinal chemistry.
[42] Stephen R. Wilson,et al. Trisamine C(60)-fullerene adducts inhibit neuronal nitric oxide synthase by acting as highly potent calmodulin antagonists. , 2002, Archives of biochemistry and biophysics.
[44] Maurizio Prato,et al. Excited-State Properties of C60 Fullerene Derivatives , 2000 .
[45] V. Knight,et al. A fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture. , 2005, Journal of the American Chemical Society.
[46] L. Ho,et al. Local carboxyfullerene protects cortical infarction in rat brain , 2002, Neuroscience Research.
[47] Richard A. Friesner,et al. Integrated Modeling Program, Applied Chemical Theory (IMPACT) , 2005, J. Comput. Chem..
[48] Li Xiao,et al. The water-soluble fullerene derivative "Radical Sponge" exerts cytoprotective action against UVA irradiation but not visible-light-catalyzed cytotoxicity in human skin keratinocytes. , 2006, Bioorganic & medicinal chemistry letters.
[49] R. Luxenhofer,et al. Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly(2-oxazoline)s nanoformulation. , 2011, Biomaterials.
[50] G. Miller,et al. Nanobionics of Pharmacologically Active Derivatives of Fullerene C60 , 2003 .
[51] Stephen R. Wilson,et al. Anti-human immunodeficiency virus activity and cytotoxicity of derivatized buckminsterfullerenes , 1996 .
[52] P. Roy,et al. On Some Aspects of Variable Selection for Partial Least Squares Regression Models , 2008 .
[53] Serdar Durdagi,et al. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations. , 2008, Bioorganic & medicinal chemistry.
[54] Jerzy Leszczynski,et al. Multiplicative SMILES-based optimal descriptors: QSPR modeling of fullerene C60 solubility in organic solvents , 2007 .
[55] Jerzy Leszczynski,et al. Structure-toxicity relationships of nitroaromatic compounds , 2006, Molecular Diversity.
[56] N. Monteiro-Riviere,et al. Penetration of intact skin by quantum dots with diverse physicochemical properties. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[57] Jerzy Leszczynski,et al. Choosing safe dispersing media for C60 fullerenes by using cytotoxicity tests on the bacterium Escherichia coli. , 2010, Journal of hazardous materials.
[58] Roberto Todeschini,et al. Structure/Response Correlations and Similarity/Diversity Analysis by GETAWAY Descriptors, 1. Theory of the Novel 3D Molecular Descriptors , 2002, J. Chem. Inf. Comput. Sci..
[59] Fred Wudl,et al. Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification , 1993 .
[60] J. Leszczynski,et al. Aconitum and Delphinium alkaloids of curare-like activity. QSAR analysis and molecular docking of alkaloids into AChBP. , 2010, European journal of medicinal chemistry.
[61] V. Subramanian,et al. Exploring the changes in the structure of α-helical peptides adsorbed onto a single walled carbon nanotube using classical molecular dynamics simulation. , 2010, The journal of physical chemistry. B.
[62] Jerzy Leszczynski,et al. Fullerene (C60) forms stable complex with nucleic acid base guanine , 2009 .
[63] M. Shukla,et al. Interaction of nucleic acid bases and Watson–Crick base pairs with fullerene: Computational study , 2010 .
[64] Jan Balzarini,et al. Synthesis and anti-HIV properties of new water-soluble bis-functionalized[60]fullerene derivatives. , 2003, Bioorganic & medicinal chemistry letters.
[65] Jerzy Leszczynski,et al. A Quantitative Structure‐Activity Relationship (QSAR) Study of the Antioxidant Activity of Flavonoids , 2005 .
[66] Gerhard F. Ecker,et al. Topological Distance Based 3D Descriptors for Use in QSAR and Diversity Analysis , 2004, J. Chem. Inf. Model..
[67] Michael R Hamblin,et al. Photodynamic therapy with fullerenes in vivo: reality or a dream? , 2011, Nanomedicine.
[68] M. Prato,et al. Anti-HIV properties of cationic fullerene derivatives. , 2005, Bioorganic & medicinal chemistry letters.
[69] A. Mikos,et al. Water-Soluble Fullerene (C60) Derivatives as Nonviral Gene-Delivery Vectors , 2008, Molecular pharmaceutics.
[70] Petra Schneider,et al. Distance phenomena in high‐dimensional chemical descriptor spaces: Consequences for similarity‐based approaches , 2009, J. Comput. Chem..
[71] James Andrew McCammon,et al. A virtual screening study of the acetylcholine binding protein using a relaxed-complex approach , 2009, Comput. Biol. Chem..
[72] Yves Rubin,et al. Sequential {open_quotes}double-Michael{close_quotes} additions of dienolates with C{sub 60}: Rapid access to sterically congested Buckminsterfullerene derivatives with defined stereochemistry , 1995 .
[73] Kunal Roy,et al. Some case studies on application of “rm2” metrics for judging quality of quantitative structure–activity relationship predictions: Emphasis on scaling of response data , 2013, J. Comput. Chem..
[74] S. C. O'brien,et al. C60: Buckminsterfullerene , 1985, Nature.
[75] Jerzy Leszczynski,et al. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. , 2011, Nature nanotechnology.
[76] Jerzy Leszczynski,et al. SMILES‐based optimal descriptors: QSAR analysis of fullerene‐based HIV‐1 PR inhibitors by means of balance of correlations , 2009, J. Comput. Chem..
[77] Jerzy Leszczynski,et al. InChI-based optimal descriptors: QSAR analysis of fullerene[C60]-based HIV-1 PR inhibitors by correlation balance. , 2010, European journal of medicinal chemistry.
[78] G L Kenyon,et al. Optimizing the binding of fullerene inhibitors of the HIV-1 protease through predicted increases in hydrophobic desolvation. , 1998, Journal of medicinal chemistry.
[79] A. Tropsha,et al. Quantitative nanostructure-activity relationship modeling. , 2010, ACS nano.
[80] Jerzy Leszczynski,et al. QSAR modeling of measured binding affinity for fullerene-based HIV-1 PR inhibitors by CORAL , 2010 .
[81] J. Huuskonen. QSAR modeling with the electrotopological state indices: predicting the toxicity of organic chemicals. , 2003, Chemosphere.
[82] J. Huff,et al. HIV protease: a novel chemotherapeutic target for AIDS. , 1991, Journal of medicinal chemistry.
[83] Ruhong Zhou,et al. Plugging into proteins: poisoning protein function by a hydrophobic nanoparticle. , 2010, ACS nano.